ANGO - AngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoption
2025-04-02 10:21:41 ET
More on AngioDynamics
- AngioDynamics, Inc. 2025 Q3 - Results - Earnings Call Presentation
- AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript
- AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
- AngioDynamics beats top-line and bottom-line estimates; updates FY25 outlook
- AngioDynamics Non-GAAP EPS of -$0.04 beats by $0.07, revenue of $73.02M beats by $2.09M